These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan. Lin WP, Huang YS, Wang JT, Chen YC, Chang SC. BMC Infect Dis; 2019 Mar 12; 19(1):245. PubMed ID: 30866828 [Abstract] [Full Text] [Related]
3. Comparison of antimicrobial resistances and clinical features in community-onset Escherichia coli and Klebsiella pneumoniae bacteremia. Sung HS, Lee JW, Bae S, Kwon KT. Korean J Intern Med; 2021 Mar 12; 36(2):433-440. PubMed ID: 32229796 [Abstract] [Full Text] [Related]
4. E. coli, K. pneumoniae and K. oxytoca community-acquired infections susceptibility to cephalosporins and other antimicrobials in Lebanon. Moghnieh RA, Musharrafieh UM, Husni RN, Abboud E, Haidar M, Abboud E, Abou Shakra D. J Med Liban; 2014 Mar 12; 62(2):107-12. PubMed ID: 25011373 [Abstract] [Full Text] [Related]
5. Community-onset Escherichia coli and Klebsiella pneumoniae bacteremia: influence of health care exposure on antimicrobial susceptibility. Sun HY, Chen SY, Chang SC, Pan SC, Su CP, Chen YC. Diagn Microbiol Infect Dis; 2006 Jun 12; 55(2):135-41. PubMed ID: 16529901 [Abstract] [Full Text] [Related]
7. Changing trends in clinical characteristics and antibiotic susceptibility of Klebsiella pneumoniae bacteremia. Hyun M, Noh CI, Ryu SY, Kim HA. Korean J Intern Med; 2018 May 12; 33(3):595-603. PubMed ID: 29117671 [Abstract] [Full Text] [Related]
9. Third-Generation Cephalosporin Resistance and Associated Discordant Antibiotic Treatment in Emergency Department Febrile Urinary Tract Infections. Mark DG, Hung YY, Salim Z, Tarlton NJ, Torres E, Frazee BW. Ann Emerg Med; 2021 Sep 12; 78(3):357-369. PubMed ID: 33781606 [Abstract] [Full Text] [Related]
10. Association between the rate of third generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae and antibiotic consumption based on 143 Chinese tertiary hospitals data in 2014. Yang P, Chen Y, Jiang S, Shen P, Lu X, Xiao Y. Eur J Clin Microbiol Infect Dis; 2020 Aug 12; 39(8):1495-1502. PubMed ID: 32221726 [Abstract] [Full Text] [Related]
12. The clinical epidemiology and outcomes of bacteremic biliary tract infections caused by antimicrobial-resistant pathogens. Sung YK, Lee JK, Lee KH, Lee KT, Kang CI. Am J Gastroenterol; 2012 Mar 12; 107(3):473-83. PubMed ID: 22334249 [Abstract] [Full Text] [Related]
14. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, Xie X. Intensive Care Med; 2002 Dec 12; 28(12):1718-23. PubMed ID: 12447513 [Abstract] [Full Text] [Related]
16. [Analysis on distribution and drug resistance of pathogen caused community-onset bloodstream infection]. Mao S, Ge Z, Zhao H, Cao J, Xia Z. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jan 12; 31(1):67-72. PubMed ID: 30707872 [Abstract] [Full Text] [Related]
18. Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems. Joo EJ, Park DA, Lee NR, Moon SY, Choi JK, Ko JH, Peck KR. Eur J Clin Microbiol Infect Dis; 2017 Nov 12; 36(11):2093-2100. PubMed ID: 28643188 [Abstract] [Full Text] [Related]
20. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. Cho YH, Jung SI, Chung HS, Yu HS, Hwang EC, Kim SO, Kang TW, Kwon DD, Park K. Int Urol Nephrol; 2015 Jul 12; 47(7):1059-66. PubMed ID: 26026972 [Abstract] [Full Text] [Related] Page: [Next] [New Search]